Stay updated on ENLIVEN Trial Assessing BIO89-100 in NASH
Sign up to get notified when there's something new on the ENLIVEN Trial Assessing BIO89-100 in NASH page.

Latest updates to the ENLIVEN Trial Assessing BIO89-100 in NASH page
- Check7 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page has undergone significant content removal regarding a clinical study on BIO89-100 for NASH, including details about the study's design, inclusion and exclusion criteria, and the study director's name. A new revision number has been added.SummaryDifference7%
- Check29 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 7, 2025, while a previous date of March 25, 2025, has been removed.SummaryDifference0.4%
- Check36 days agoNo Change Detected
- Check72 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe page now indicates that some NLM-NCBI services and products are experiencing heavy traffic, which may impact their performance and availability. Additionally, there are updates regarding specific dates related to the services.SummaryDifference2%
- Check94 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to ENLIVEN Trial Assessing BIO89-100 in NASH
Enter your email address, and we'll notify you when there's something new on the ENLIVEN Trial Assessing BIO89-100 in NASH page.